Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with Adriamycin-induced nephrotic syndrome

Journal of Nephrology

Volumn 21, Issue 4, 2008, Pages 576-583

  Bulucu, Fatih ^a   Oktenli, Cagatay ^b   Kenar, Levent ^a   Ocal, Ramazan ^a   Koc, Bayram ^a   Inal, Volkan ^a   Yamanel, Levent ^a   Yaman, Halil ^a   Sanisoglu, Yavuz S ^c   Aydin, Ahmet ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^c MINISTRY OF HEALTH   (Turkey)

Author keywords

Adriamycin; Deferoxamine; N Acetylcysteine; Nephrotic syndrome; Selenium

Indexed keywords

ACETYLCYSTEINE; CATALASE; COPPER; DEFEROXAMINE; DOXORUBICIN; GLUTATHIONE PEROXIDASE; LIPID; MALONALDEHYDE; SELENIUM; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TRACE ELEMENT; ZINC; ANTINEOPLASTIC ANTIBIOTIC; CREATININE; SCAVENGER; SIDEROPHORE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE; HISTOPATHOLOGY; HYPOALBUMINEMIA; KIDNEY INJURY; KIDNEY PARENCHYMA; LIPID BLOOD LEVEL; MALE; NEPHROTIC SYNDROME; NONHUMAN; PROTEINURIA; RAT; RENAL PROTECTION; SINGLE DRUG DOSE; SPRAGUE DAWLEY RAT; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; COLORIMETRY; COMPARATIVE STUDY; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECT; KIDNEY; METABOLISM; OXIDATIVE STRESS; TREATMENT OUTCOME; URINE;

ACETYLCYSTEINE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; COLORIMETRY; CREATININE; DEFEROXAMINE; DISEASE MODELS, ANIMAL; DOXORUBICIN; DRUG THERAPY, COMBINATION; ERYTHROCYTES; FREE RADICAL SCAVENGERS; KIDNEY; MALE; NEPHROTIC SYNDROME; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SELENIUM; SIDEROPHORES; TREATMENT OUTCOME;

EID: 52649142766     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ozata M, Mergen M, Oktenli C, et al. Increased oxidative stress and hypozincemia in male obesity. Clin Biochem. 2002;35:627-631.
2. Bulucu F, Vural A, Aydin A, Sayal A. Oxidative stress status in adults with nephrotic syndrome. Clin Nephrol. 2000;53:169-173.
3. Diamond JR. The role of reactive oxygen species in animal models of glomerular disease. Am J Kidney Dis. 1992;19:292-300.
4. Venkatesan N, Venkatesan P, Karthikeyan J, Arumugam V. Protection by taurine against Adriamycin-induced proteinuria and hyperlipidemia in rats. Proc Soc Exp Biol Med. 1997;215:158-164.
5. Park ES, Kim SD, Lee MH, et al. Protective effects of N-acetylcysteine and selenium against doxorubicin toxicity in rats. J Vet Sci. 2003;4:129-136.
6. Bertolatus JA, Klinzman D, Bronsema DA, Ridnour L, Oberley LW. Evaluation of the role of reactive oxygen species in doxorubicin hydrochloride nephrosis. J Lab Clin Med. 1991;118:435-445.
7. Pleban PA, Munyani A, Beachum J. Determination of selenium concentration and glutathione peroxidase activity in plasma and erythrocytes. Clin Chem. 1982;28:311-316.
8. Fitzgerald SP, Campbell JJ, Lamont JV. The establishment of reference ranges for selenium. Selenoenzyme glutathione peroxidase and the metalloenzyme superoxide dismutase in blood fractions. The fifth international symposium on selenium in biology and medicine. Tennessee, USA, July 20-23, 1992.
9. Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Isimer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clin Biochem. 2001;134:65-70.
10. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-126.
11. Barbey MM, Fels LM, Soose M, et al. Adriamycin affects glomerular renal function: evidence for the involvement of oxygen radicals. Free Radic Res Commun. 1989;7:195-203.
12. Rangan GK, Wang Y, Tay YC, Harris DC. Cytokine gene expression in Adriamycin nephropathy: effects of antioxidant nuclear factor kappaB inhibitors in established disease. Nephron. 2000;86:482-490.
13. Kalaiselvi P, Pragasam V, Chinnikrishnan S, Veena CK, Sundarapandiyan R, Varalakshmi P. Counteracting Adriamycin-induced oxidative stress by administration of N-acetyl cysteine and vitamin E. Clin Chem Lab Med. 2005;43:834-840.
14. Zima T, Tesar V, Stipek S, et al. The influence of cyclosporine on lipid peroxidation and superoxide dismutase in Adriamycin nephropathy in rats. Nephron. 1997;75:464-468.
15. Saad SY, Najjar TA, Al-Rikabi AC. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res. 2001;43:211-218.
16. Bertani T, Poggi A, Pozzoni R, et al. Adriamycin-induced nephrotic syndrome in rat: sequence of pathologic events. Lab Invest. 1982;46:16-23.
17. Sagrista ML, Garcia AF, Madariaga MA, Mora M. Antioxidant and pro-oxidant effect of the thiolic compounds N-acetyl-l-cysteine and glutathione against free radical-induced lipid peroxidation. Free Radic Res. 2002;36:329-340.
18. Corna G, Santambrogio P, Minotti G, Cairo G. Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: Role of reactive oxygen species and ferritin. J Biol Chem. 2004;279:13738-13745.
19. Maret W. Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid Redox Signal. 2006;8:1419-1441.
20. Martell AE, Smith RM. Critical stability constants amino acids. New York, NY: Plenum Press; 1974.
21. Brumas V, Hacht B, Filella M, Berthon G. Can N-acetyl-L-cysteine affect zinc metabolism when used as a paracetamol antidote? Agents Actions. 1992;36:278-288.
22. Powis G. Free radical formation by antitumor quinones. Free Radic Biol Med. 1989;6:63-101.
23. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med. 1995;18:321-336.
24. Hochstein P, Kumar KS, Forman SJ. Lipid peroxidation and the cytotoxicity of copper. Ann N Y Acad Sci. 1980;355:240-248.
25. Hermansen K, Wassermann K. The effect of vitamin E and selenium on doxorubicin (Adriamycin) induced delayed toxicity in mice. Acta Pharmacol Toxicol (Copenh). 1986;58:31-37.
26. Van Vleet JF, Ferrans VJ. Evaluation of vitamin E and selenium protection against chronic Adriamycin toxicity in rabbits. Cancer Treat Rep. 1980;64:315-317.
27. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 2nd ed. Oxford: Clarendon Press; 1989.